Karuna Therapeutics (KRTX) PEG Ratio
Market Cap: $12.60B
Avg Volume: 971.83K
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Karuna Therapeutics's trailing twelve month (TTM) PEG ratio is 4.97.
- Karuna Therapeutics's annual PEG ratio as of today is -0.79.
- Karuna Therapeutics's quarterly PEG ratio is 5.53.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Karuna Therapeutics's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -26.97
- Quarterly: -26.26
- TTM: -37.08
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 17886.71
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 9.33
- Quarterly: 9.53
- TTM: 9.94
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -30.32
- Quarterly: -107.67
- TTM: -43.69
These metrics provide insights into Karuna Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
4.97
Annual PEG Ratio
-0.79
Quarterly PEG Ratio
5.53
Karuna Therapeutics Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Karuna Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2023 | -0.79 | -26.97 | 17886.71 | 9.33 | -30.32 |
| 2022 | -0.29 | -22.49 | 584.29 | 5.52 | -27.26 |
| 2021 | -0.29 | -26.54 | 103.27 | 7.60 | -37.84 |
| 2020 | 1.27 | -39.19 | 0.00 | 7.93 | -38.46 |
| 2019 | -0.15 | -20.09 | 0.00 | 2.31 | -29.13 |
| 2018 | -0.13 | -12.42 | 0.00 | 2.38 | -14.15 |
| 2017 | 0.00 | -24.63 | 0.00 | -11.11 | -36.89 |
Related Metrics
Explore detailed financial metrics and analysis for KRTX.